Sign up to save your podcasts
Or
Share Semaglutide and Heart Failure with Preserved Ejection Fraction: Key Findings
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Semaglutide and Heart Failure with Preserved Ejection Fraction: Key Findings
In this episode of the Heartbeat Podcast, we delve into the latest findings from a pooled analysis of pivotal clinical trials—SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM. This study uncovers the impact of semaglutide, a GLP-1 receptor agonist, on patients with heart failure with preserved ejection fraction (HFpEF), particularly those struggling with obesity. Join us as we explore how this treatment reduces heart failure events and discuss its implications for clinical practice. With HFpEF being a challenging condition to treat, this episode highlights hope for patients and clinicians alike.
Stay tuned for an insightful discussion, statistics, and the potential future of HFpEF management!
Listen to the Episode Here:
#HFpEF #HeartFailure #Semaglutide #MedicalResearch #Cardiology #HeartHealth #Obesity #Podcast #MedicalScience #GLP1ReceptorAgonist#SELECTStudy #FLOWTrial #STEP_HFpEF #STEP_HFpEF_DM
View all episodes
By Mohammed Al-QadamiIn this episode of the Heartbeat Podcast, we delve into the latest findings from a pooled analysis of pivotal clinical trials—SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM. This study uncovers the impact of semaglutide, a GLP-1 receptor agonist, on patients with heart failure with preserved ejection fraction (HFpEF), particularly those struggling with obesity. Join us as we explore how this treatment reduces heart failure events and discuss its implications for clinical practice. With HFpEF being a challenging condition to treat, this episode highlights hope for patients and clinicians alike.
Stay tuned for an insightful discussion, statistics, and the potential future of HFpEF management!
Listen to the Episode Here:
#HFpEF #HeartFailure #Semaglutide #MedicalResearch #Cardiology #HeartHealth #Obesity #Podcast #MedicalScience #GLP1ReceptorAgonist#SELECTStudy #FLOWTrial #STEP_HFpEF #STEP_HFpEF_DM